Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/30/2019 | 04:05am EDT

DGAP Total Voting Rights Announcement: Fresenius SE & Co. KGaA / Total Voting Rights Announcement
Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

30.06.2019 / 10:00
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuer
Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 30.06.2019
  Other capital measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:
556842018



30.06.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany
Internet: www.fresenius.com

 
End of News DGAP News Service

832905  30.06.2019 

fncls.ssp?fn=show_t_gif&application_id=832905&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS SE & CO. KGAA
12:17pFRESENIUS : Vamed completes main university hospital building in Kiel
PU
08/15FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
08/12FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by ..
EQ
08/09FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by ..
EQ
08/05FRESENIUS : Helios expands preventive medicine offering
PU
07/31FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
07/30Bridgepoint tests appetite for $2.2 billion dialysis clinic firm Diaverum - s..
RE
07/30Fresenius slides as weakness in dialysis unit offsets improved outlook
RE
07/30FRESENIUS : Medical Care on track to achieve full-year targets after solid secon..
PU
07/30FRESENIUS MEDICAL CARE : Trades Lower After 2Q Results
DJ
More news
Financials (EUR)
Sales 2019 35 505 M
EBIT 2019 4 666 M
Net income 2019 1 836 M
Debt 2019 20 580 M
Yield 2019 1,83%
P/E ratio 2019 13,1x
P/E ratio 2020 12,0x
EV / Sales2019 1,26x
EV / Sales2020 1,13x
Capitalization 24 301 M
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 56,94  €
Last Close Price 43,57  €
Spread / Highest target 71,7%
Spread / Average Target 30,7%
Spread / Lowest Target -25,5%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors